Esomeprazole Sodium Injection, Powder, Lyophilized, For Solution
Product Images NDC 70436-190

2 FDA label images from Slate Run Pharmaceuticals, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Esomeprazole Sodium (NDC 70436-190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Image 1)

Formula (Image 1)
Chemical structure diagram of esomeprazole sodium, showing the molecular arrangement including a sulfoxide group, a pyridine ring, and a benzimidazole ring with methoxy groups, with sodium ion indicated.*
FDA Label Image

Carton-40 mg-v1.2 (Image 3)

Carton-40 mg-v1.2 (Image 3)
Packaging label for Esomeprazole Sodium for Injection 40 mg/vial, an intravenous lyophilized powder for solution. The box contains 10 single-dose vials. Labeler is Slate Run Pharmaceuticals, LLC. Box includes NDC 70436-190-82 and states use for intravenous use only with instructions to discard unused portion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.